Global Polycystic Ovary Syndrome Market

Description:-

WiseGuyReports.com “Global Polycystic Ovary Syndrome Market 2018: Global Analysis, Industry Size, Share, Trends, Application Analysis and Growth Opportunities Forecast to 2023” report has been added to its Research Database.

Polycystic ovary syndrome market is a hormonal disorder observed in females of reproductive ages. The disorder causes the excessive production of hormones in the female body, which include testosterone or androgens, hormones that are primarily associated with the male reproductive system. PCOS includes a range of symptoms such as irregular menstrual cycle, trouble in getting pregnant, cyst formation in the ovaries, excessive body and facial hair, and pelvic pain, among others. Moreover, the early diagnosis of the disorder is highly recommended by the physicians, as untreated PCOS may often lead to high cholesterol, type-2 diabetes, heart disease, insulin resistance, and high blood pressure.

Major factors contributing to the growth of the global polycystic ovary syndrome market include sedentary lifestyle and faulty dietary habits and increasing female obese population across the globe. Initiatives taken by the government and non-profit organizations to spread awareness regarding the early diagnosis of the disorder is significantly fueling the market growth. Moreover, increasing genetic and hormonal disorder in female population is a major cause for the increase of polycystic ovary syndrome patients across the globe. Lack of regulatory approved drugs for the treatment of PCOS and easy availability of generic and off-label drugs may restrain the growth of the global PCOS market. However, market players are focusing in the development of innovative and symptom specific drugs are expected to fuel the market growth in the near future.

Global polycystic ovary syndrome market is segmented on the basis of regional outlook and following segments:
1. Global Polycystic Ovary Syndrome Market Research and Analysis, By Drug Type
2. Global Polycystic Ovary Syndrome Market Research and Analysis, By Diagnosis Type
3. Global Polycystic Ovary Syndrome Market Research and Analysis, By Treatment Type
4. Global Polycystic Ovary Syndrome Market Research and Analysis, By Distribution Channel
5. Global Polycystic Ovary Syndrome Market Research and Analysis, By Region

Browse sample report @ http://www.wiseguyreports.com/sample-request/3271377-global-polycystic-ovary-syndrome-market-research-and-forecast-2018-2023

Companies Mentioned

ABBOTT LABORATORIES
2. ADDEX THERAPEUTICS
3. ANAX
4. ASTELLAS PHARMA, INC.
5. ASTRAZENECA
6. AVA SCIENCE INC.
7. BAYER AG
8. BRISTOL-MYERS SQUIBB COMPANY
9. DEXA MEDICA
10. FERRING PHARMACEUTICALS
Table of Content

CHAPTER 1. REPORT SUMMARY
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS

CHAPTER 2. MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. ANALYST INSIGHT & CURRENT MARKET TRENDS
2.2.1. KEY FINDINGS
2.2.2. RECOMMENDATION
2.2.3. CONCLUSION
2.3. REGULATIONS
2.3.1.1. UNITED STATES
2.3.1.2. EUROPEAN UNION
2.3.1.3. CHINA
2.3.1.4. INDIA

CHAPTER 3. MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. INCREASING OBESITY IN WOMEN
3.1.2. INITIATIVES TAKEN BY GOVERNMNET BODIES ABOUT EARLY DIAGNOSIS OF THE DISORDER
3.1.3. SEDENTARY LIFESTYLE AND FAULTY DIETARY HABITS
3.1.4. INCREASING GENETIC AND HORMONAL DISORDERS
3.2. RESTRAINTS
3.2.1. LACK OF APPROVED DRUGS FOR PCOS TREATMENT
3.2.2. EASY AVAILABILITY OF GENERIC AND OFF-LABEL DRUGS
3.3. OPPORTUNITIES
3.3.1. TECHNOLOGICAL ADVANCEMENTS AND INNOVATIONS FOCUSING ON DEVELOPMENT OF SYMPTOM-SPECIFIC DRUGS

CHAPTER 4. MARKET SEGMENTATION
4.1. GLOBAL POLYCYSTIC OVARY SYNDROME MARKET, BY DRUG TYPE
4.1.1. DIURETICS
4.1.2. INSULIN SENSITIZING AGENTS
4.1.3. ANTIANDROGENS
4.1.4. ANTI-DEPRESSANTS
4.1.5. ORNITHINE DECARBOXYLASE INHIBITORS
4.1.6. ANTI-OBESITY
4.1.7. ORAL CONTRACEPTIVE PILLS
4.2. GLOBAL POLYCYSTIC OVARY SYNDROME MARKET, BY DIAGNOSIS TYPE
4.2.1. ULTRASOUND
4.2.2. PELVIC EXAM
4.2.3. BLOOD TEST
4.3. GLOBAL POLYCYSTIC OVARY SYNDROME MARKET, BY TREATMENT TYPE
4.3.1. OVARIAN WEDGE RESECTION
4.3.2. LAPAROSCOPIC OVARIAN DRILLING
4.3.3. ACUPUNCTURE
4.4. GLOBAL POLYCYSTIC OVARY SYNDROME MARKET BY DISTRIBUTION CHANNEL
4.4.1. HOSPITAL PHARMACIES
4.4.2. RETAIL PHARMACIES (ONLINE AND OFFLINE)
4.4.3. FERTILITY CLINICS

TOC Continued……….

Browse full report @ https://www.wiseguyreports.com/reports/3271377-global-polycystic-ovary-syndrome-market-research-and-forecast-2018-2023





About Us:

Wise Guy Reports Is Part Of The Wise Guy Consultants Pvt. Ltd. And Offers Premium Progressive Statistical Surveying, Market Research Reports, Analysis & Forecast Data For Industries And Governments Around The Globe. Wise Guy Reports Features An Exhaustive List Of Market Research Reports From Hundreds Of Publishers Worldwide. We Boast A Database Polycystic Ovary Syndromenning Virtually Every Market Category And An Even More Comprehensive Collection Of Market Research Reports Under These Categories And Sub-Categories.



Contact Us:

Wise Guy Research Consultants Pvt Ltd

[email protected]

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

Maharashtra, Pune – 411028